Port delivery system: a novel drug delivery platform to treat retinal diseases.

Arshad M Khanani Aamir A AzizChristina Y WengWeijie Violet LinJordyn VannavongJay ChhablaniCarl J DanzigPeter K Kaiser

Published in: Expert opinion on drug delivery (2021)

PDS is a novel drug delivery platform for the treatment of retinal diseases. Currently, the data from the PDS has shown promising efficacy and ability to substantially mitigate treatment burden while effectively generating visual and anatomic outcomes similar to those in patients receiving the standard monthly ranibizumab for neovascular age-related macular degeneration. Further studies are ongoing to investigate this novel drug delivery system in other disease states.

Keyphrases

age related macular degeneration
drug delivery
diabetic retinopathy
optical coherence tomography
type diabetes
adipose tissue
cancer therapy
machine learning
electronic health record
skeletal muscle
big data
optic nerve
weight loss
data analysis
smoking cessation